Dr David W Allison, MD | |
384 Hospital Dr, Warrenton, VA 20186-3006 | |
(540) 347-4266 | |
(540) 349-1261 |
Full Name | Dr David W Allison |
---|---|
Gender | Male |
Speciality | Plastic Surgery |
Location | 384 Hospital Dr, Warrenton, Virginia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972598142 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 0101232945 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr David W Allison, MD 384 Hospital Dr, Warrenton, VA 20186-3006 Ph: (540) 347-4266 | Dr David W Allison, MD 384 Hospital Dr, Warrenton, VA 20186-3006 Ph: (540) 347-4266 |
News Archive
A new study published on the medRxiv* preprint server analyzed the trajectories of anti-SARS-CoV-2 antibodies in patients from the RituxiVac study were compared to healthy volunteers. In addition, they investigated the immunogenicity of a third vaccine dose in previously non-responding patients.
Replacing dopamine-producing cells in the brain represents a promising therapeutic approach in Parkinson's disease, and a new study shows how post-transplantation gamma-ray irradiation can reduce the risk of tumor formation.
Trillium Therapeutics Inc., a privately-held biopharmaceutical company, announced today that it has raised $1 million from a new undisclosed investor. The funds will be used to advance its lead program, TTI-1612, into clinical trials for the treatment of interstitial cystitis, also known as bladder pain syndrome. The first trial is projected to start in the second half of this year.
A group of researchers re-evaluated their previously proposed hypothesis, which stated that the TLR4 activated by the spike glycoprotein S1 domain increases ACE2 expression and, thereby, aids in COVID-19 infection.
› Verified 4 days ago